Arbid N Drops - Body Care Products
Arbid N Tropfen Fl 30 ml
-
23.17 USD
- Availability: In stock
- Brand: VERFORA AG
- Product Code: 4868528
- ATC-code R06AB04
- EAN 7680583730018
Ingredient:
Point your phone at the qr code
Share on social networks
Description
What is Arbid N, oral drops and when is it used?
Arbid N contains an antihistamine, chlorphenamine maleate. It is used in inflammatory and allergic diseases of the upper respiratory tract such as colds, hay fever, chronic runny nose, vasomotor or allergic rhinitis, rhinopharyngitis, allergic sinusitis and as an adjuvant in influenza and colds. For the symptomatic treatment of allergic conditions such as urticaria (nettle rash), conjunctivitis (conjunctivitis).
When should Arbid N, drops to be used not be used?
If you are sensitive to any component of the drug, at risk of narrow-angle glaucoma (increased pressure in the eye) or have difficulty urinating, or during concomitant treatment and for up to 2 weeks after stopping treatment with certain drugs for depression (especially MAO-He always). In addition, Arbid N must not be used during the last trimester of pregnancy or while breastfeeding (see «Can Arbid N be taken during pregnancy and while breastfeeding?»).
Arbid N must not be used in children under the age of 3 years.
When should caution be taken when taking/using Arbid N, oral drops?
Arbid N must not be used for a long time or in higher than recommended doses without medical advice.
Stepping Allergic reactions to or narrowing of the bronchi with breathing difficulties, so-called bronchospasm (see under «What side effects can Arbid N have?»), the treatment must be stopped immediately and the doctor informed.
This medicine can impair the ability to react, the ability to drive and the ability to use tools or machines.
Arbid N contains sucrose. Therefore, if you know that you have an intolerance to certain sugars, please consult your doctor before taking Arbid N before taking Arbid N.
Arbid N contains sodium methyl parahydroxybenzoate (E219) and sodium propyl parahydroxybenzoate (E217), which may cause allergic reactions (possibly delayed).
This medicinal product contains less than 1 mmol sodium (23 mg) per gram (20 drops), i.e. it is almost «sodium-free».
Inform your doctor, pharmacist or pharmacist or your doctor, pharmacist or pharmacist if you suffer from other illnesses, have allergies or are taking other medicines (including those you bought yourself!) or using them externally.
May Arbid N, swallow drops be taken/used during pregnancy or while breastfeeding?
If you foresee becoming pregnant, if you If you are pregnant or breastfeeding, you should avoid taking medicines. It is known that taking Arbid N during the last trimester can adversely affect the health of the fetus. For this reason, Arbid N must not be taken during the last trimester. Arbid N can be taken during the first and second trimester if there is a strong indication and if the doctor prescribes it.
Arbid N must not be taken during breast-feeding. However, if you absolutely have to take Arbid N when prescribed by a doctor, you must refrain from breastfeeding.
How do you use Arbid N, drops to swallow?
Unless otherwise prescribed by the doctor, the usual dosage for children aged 3-5 years is: 10 drops 4-6 times a day; for children aged 6-12 years: 20 drops 4-6 times a day, for adults: 40 drops 4-6 times a day.
Preferably take between meals.
Observe the dosage given in the package leaflet or described by your doctor. WhomIf you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.
What side effects can Arbid N, swallow drops have?
The following side effects can occur when taking Arbid N:
Sensitive people can have allergic reactions (rash, itching, increased heart rate, breathing disorders, loss of consciousness). In this case, you should stop taking the medicine and talk to your doctor as soon as possible.
If you take an overdose of the active ingredient chlorphenamine, you may experience cramps, difficulty breathing, even acute shortness of breath and coma. Children, especially small children, react with particular sensitivity if the dosage is too high.
Common (affects 1 to 10 users in 100)
Drowsiness and reduced responsiveness (see «When should caution be taken when taking/using Arbid N, drops to swallow?»).
Uncommon (affects 1 to 10 users in 1000)
Stomach and intestinal disorders such as constipation; dry mouth; trouble urinating; visual disturbances (accommodation disorders); increase in intraocular pressure; restlessness (especially in children); Nervousness; Sleep disturbances.
Occasionally
Skin rash and bone marrow depression.
If you nevertheless observe side effects, inform your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet.
What else needs to be taken into account?
The medicine may only be used up to the date marked «EXP» on the container.
Storage instructions
Store Arbid N at room temperature (15-25 °C) in the original packaging out of the reach of children. Close the opened container carefully after taking a dose.
Further information
The Arbid N bottles have a child-resistant closure. To open, the cap must be pressed down and turned at the same time. The childproof lock is only effective if the cap is firmly screwed on as far as it will go after use.
Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed technical information.
What does Arbid N, drops to swallow contain?
1 g (approx. 20 drops) drops to swallow contains:
Active ingredients
2 mg chlorphenamine maleate.
Excipients
Sucrose, citric acid monohydrate, sodium methyl(4-hydroxybenzoate) (E 219), sodium propyl(4-hydroxy benzoate) (E 217), orange aroma, purified water.
Authorization number
58373 (Swissmedic).
Where can you get Arbid N, drops to swallow? Which packs are available?
In pharmacies and drugstores, without a doctor's prescription, in 30 ml dropper bottles.
Authorization holder
VERFORA SA, 1752 Villars-sur-Glâne.
This leaflet was last checked by the medicinal products authority (Swissmedic) in December 2020.